CD47 and neoplasm: When CSPG4-targeting CAR-Ms are combined with CD47 blocking antibodies, thereby blocking a key tumor cell “don’t eat me” signal, we observe enhanced phagocytosis of melanoma cells and robust inhibition of melanoma spheroid growth in 3D.